The effect of lactose consumption in lactase non-persistent individuals on gut microbiota - Lactastic

Wageningen Universiteit0 个研究点目标入组 25 人开始时间: 待定最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•* Any metabolic, gastrointestinal, inflammatory or chronic disease (such as
•diabetes, anaemia, hepatitis, cardiovascular disease)
•* History of gastro-intestinal surgery or having (serious) gastrointestinal
•* Use of pre- and/or probiotics
•* Use of medication that may influence the study results, such as laxatives and
•lactase peparations (e.g. Kerutab). Use of medication will be judged by the
•medical supervisor
•* Having used antibiotics in the 6 months prior to the start of the study
•* Reported slimming or medically prescribed diet
•* Current smokers
•* Alcohol intake *2 (women) or *4 (men) glasses of alcoholic beverages per day
•* Pregnant or lactating (or having the wish to become pregnant during the study
•period, self-reported)
•* Abuse of illicit drugs
•* Having food allergies (no food intolerances)
•* Insufficient proficiency in English to understand information brochure and
•questionnaires
•* Participation in another clinical trial at the same time
•* Being an employee of the department Consumer Science & Health group of
•Wageningen Food & Biobased Research, Human Nutrition department of Wageningen
•University, or FrieslandCampina.

发起方